Survival Outcomes After Radiotherapy for the Treatment of Synchronous Oligometastatic Prostate Cancer

This cohort study assesses biochemical progression-free survival among patients receiving radiotherapy for the treatment of synchronous oligometastatic prostate cancer.

Detalles Bibliográficos
Autores principales: Huynh, Linda My, Bonebrake, Benjamin T., Enke, Charles, Baine, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547319/
https://www.ncbi.nlm.nih.gov/pubmed/36206000
http://dx.doi.org/10.1001/jamanetworkopen.2022.35345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547319/
https://www.ncbi.nlm.nih.gov/pubmed/36206000
http://dx.doi.org/10.1001/jamanetworkopen.2022.35345

Ejemplares similares